Companies/US/ALMR

ALAMAR BIOSCIENCES, INC.

Ownership & governance

Executives 3Directors 2Avg age 63Avg tenure 7.2y
Yu Ling Luo
Chief Executive Officer
Age 62Since 2018-06-30Profile →

Executives3

Steve Chen
Chief Operating Officer
Age 63Since 2018-07-31
Yiyuan Yin
Chief Tech/Sci/R&D Officer
—Since 2020-12-31
Yu Ling Luo
Chief Executive Officer
Age 62Since 2018-06-30

Board of directors2

Yu Ling Luo
Chairman
Age 62Since 2018-06-30
Nicholas Naclerio
Director/Board Member
Age 64Since 2020-04-30

Shareholders5

NameStakeShares
Qiming Venture Partners Ltd.
15.29 %
10,594,547
IIF Management Co. LLC
9.181 %
6,363,612
Sherpa Healthcare Partners Co Ltd.
6.919 %
4,795,663
Sands Capital Alternative LLC
6.104 %
4,230,926
Yu Ling Luo
4.566 %
3,164,726

Catalog · 2026-07-09

Registry officers5

NameRoleSinceShares
Steve ChenChief Operating Officer2018-07-31-
Yiyuan YinChief Tech/Sci/R&D Officer2020-12-31-
Yu Ling LuoChairman2018-06-30-
Yu Ling LuoChief Executive Officer2018-06-30-
Nicholas NaclerioDirector/Board Member2020-04-30-

Registry · as of 2026-07-09

Institutional (13F)

Loading Form 13F holders…

Fund membership

Loading fund baskets…

Street consensus

Consensus buyMean target 35.4Range 31–45Analysts 5
31Mean 35.445
  • Strong buy 1
  • Buy 3
  • Hold 1

Broker actions6

FirmActionToTargetDate
StifelMaintainedBuy322026-08-11
JP MorganMaintainedOverweight352026-08-11
Leerink PartnersInitiatedOutperform352026-05-12
TD CowenInitiatedBuy302026-05-12
JP MorganInitiatedOverweight302026-05-12
StifelInitiatedBuy282026-05-12

Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.

Peers